Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

177
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
177
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

121
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
121
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

215
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
215
Censoring Survival Data01:09

Censoring Survival Data

78
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
78
Cancer Survival Analysis01:21

Cancer Survival Analysis

342
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
342
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

411
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
411

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Short-chain fructo-oligosaccharides modulate gut microbiota composition and metabolism: dose-response assessment in an <i>ex vivo</i> gut model.

Gut microbes reports·2026
Same author

Drugst.One DREAM-Drug repurposing through expert annotation and modification.

British journal of pharmacology·2026
Same author

CroCoDeEL: accurate control-free detection of cross-sample contamination in metagenomic data.

Nature communications·2026
Same author

Microbiome signature of Parkinson's disease in healthy and genetically at-risk individuals.

Nature medicine·2026
Same author

The power and limits of predicting inter-protein exon-exon interactions using protein 3D structures.

Bioinformatics advances·2026
Same author

A gut microbiome-kidney-heart axis predictive of future cardiovascular diseases.

Nature communications·2026
Same journal

Supporting Radiology Resident Education and Clinical Decision-Making With Large Language Models: Comparative Study of Reasoning Models DeepSeek-R1 and ChatGPT-o1.

JMIR AI·2026
Same journal

Patient Perceptions on the Use of Artificial Intelligence in Creating Clinical Research Documents: Survey Study.

JMIR AI·2026
Same journal

Application of Language Models for the Analysis of Adverse Drug Events in Pharmaceutical Research and Development: Scoping Review.

JMIR AI·2026
Same journal

Correction: Deep Learning for Age Estimation and Sex Prediction Using Mandibular-Cropped Cephalometric Images: Comparative Model Development and Validation Study.

JMIR AI·2026
Same journal

AI-Assisted Systematic Literature Review of the Economic Burden of Pneumococcal Disease: Development and Validation Study.

JMIR AI·2026
Same journal

Knowledge-Augmented Large Language Model for Multimodal Electronic Health Record-Based Risk Prediction: Development and Validation Study.

JMIR AI·2026
See all related articles

Related Experiment Video

Updated: Jun 23, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K

Privacy-Preserving Federated Survival Support Vector Machines for Cross-Institutional Time-To-Event Analysis:

Julian Späth1, Zeno Sewald2, Niklas Probul1

  • 1Institute for Computational Systems Biology, University of Hamburg, Hamburg, Germany.

JMIR AI
|June 14, 2024
PubMed
Summary
This summary is machine-generated.

Federated learning enables privacy-preserving survival analysis across institutions. This federated survival support vector machine (SVM) achieves results comparable to centralized models, enhancing prediction accuracy with more data.

Keywords:
FeatureCloudImplementationImplementation sciencealgorithmcentralized modelfederatedfederated learningmachine learningpredictpredictionpredictionspredictiveprivacy regulationsupport vector machinesurvivalsurvival analysis

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

Related Experiment Videos

Last Updated: Jun 23, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

Area of Science:

  • Computational biology
  • Medical informatics
  • Machine learning

Background:

  • Centralized patient data collection faces privacy challenges, limiting large-scale clinical studies.
  • Federated learning offers a privacy-preserving solution for distributed medical data analysis.
  • Large sample sizes are crucial for time-to-event studies but often unavailable at single institutions.

Purpose of the Study:

  • To develop and validate a privacy-preserving federated survival support vector machine (SVM).
  • To enable cross-institutional time-to-event analyses for researchers.
  • To provide an accessible tool for federated survival analysis.

Main Methods:

  • Extended the survival SVM algorithm for federated environments.
  • Implemented the federated survival SVM as a FeatureCloud app.
  • Evaluated the algorithm on synthetic and real-world microbiome datasets, comparing it to a central model.

Main Results:

  • The federated survival SVM yielded highly similar results to the centralized model (max weight difference of 0.001).
  • Federated learning improved prediction accuracy by incorporating more data, even with site-specific batch effects.
  • The approach demonstrated robustness across benchmark datasets.

Conclusions:

  • The federated survival SVM enhances federated time-to-event analysis with a robust machine learning method.
  • The FeatureCloud app is the first publicly available federated survival SVM, freely accessible to researchers.
  • This tool facilitates direct use within the FeatureCloud platform for collaborative research.